Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Thyroid : Official Journal of the American Thyroid Association
|
May 6, 2022
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer
Nancy Y Lee, Nadeem Riaz, Vanessa Wu, et al.
Tomography (Ann Arbor, Mich.)
|
June 18, 2020
Computational Modeling of Interstitial Fluid Pressure and Velocity in Head and Neck Cancer Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Feasibility Analysis
Eve LoCastro, Ramesh Paudyal, Yousef Mazaheri, et al.
Clinical Neurology and Neurosurgery
|
May 15, 2026
Enhancing glioma progression prediction: Unsupervised clustering of whole-brain magnetic resonance spectroscopy data for surgical planning
Cameron A Rivera, Alan Ho, Venkat Uppalapati, et al.
The Lancet. Diabetes & Endocrinology
|
May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement
Sophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2020
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
Sean McBride, Eric Sherman, C Jillian Tsai, et al.
NMR in Biomedicine
|
November 5, 2019
Dynamic contrast-enhanced MRI model selection for predicting tumor aggressiveness in papillary thyroid cancers
Ramesh Paudyal, Yonggang Lu, Vaios Hatzoglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 12, 2023
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
Audrey Mauguen, Ravinder K Grewal, Finn Augensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 15, 2023
Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
Lisa Bodei, R Michael Tuttle, Ravinder K Grewal, et al.
International Journal of Particle Therapy
|
February 2, 2026
The Use of Protons in the Management of Recurrent, Previously Irradiated Adenoid Cystic Carcinoma
Irini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
International Journal of Particle Therapy
|
October 29, 2025
The Use of Proton Radiation in the Management of Adenoid Cystic Carcinoma
Irini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Thyroid : Official Journal of the American Thyroid Association
|
May 6, 2022
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer
Nancy Y Lee, Nadeem Riaz, Vanessa Wu, et al.
Tomography (Ann Arbor, Mich.)
|
June 18, 2020
Computational Modeling of Interstitial Fluid Pressure and Velocity in Head and Neck Cancer Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Feasibility Analysis
Eve LoCastro, Ramesh Paudyal, Yousef Mazaheri, et al.
Clinical Neurology and Neurosurgery
|
May 15, 2026
Enhancing glioma progression prediction: Unsupervised clustering of whole-brain magnetic resonance spectroscopy data for surgical planning
Cameron A Rivera, Alan Ho, Venkat Uppalapati, et al.
The Lancet. Diabetes & Endocrinology
|
May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement
Sophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2020
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
Sean McBride, Eric Sherman, C Jillian Tsai, et al.
NMR in Biomedicine
|
November 5, 2019
Dynamic contrast-enhanced MRI model selection for predicting tumor aggressiveness in papillary thyroid cancers
Ramesh Paudyal, Yonggang Lu, Vaios Hatzoglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 12, 2023
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
Audrey Mauguen, Ravinder K Grewal, Finn Augensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 15, 2023
Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
Lisa Bodei, R Michael Tuttle, Ravinder K Grewal, et al.
International Journal of Particle Therapy
|
February 2, 2026
The Use of Protons in the Management of Recurrent, Previously Irradiated Adenoid Cystic Carcinoma
Irini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
International Journal of Particle Therapy
|
October 29, 2025
The Use of Proton Radiation in the Management of Adenoid Cystic Carcinoma
Irini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
Page
of 8